Single Dosing of Zoledronic Acid in Cancer Therapy Induced Bone Loss (CTIBL)
This study has been completed.
Sponsor:
Penn State University
Collaborator:
Novartis
Information provided by (Responsible Party):
Allan Lipton, Penn State University
ClinicalTrials.gov Identifier:
NCT00712985
First received: July 9, 2008
Last updated: September 13, 2012
Last verified: April 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | March 2011 |
| Primary Completion Date: | March 2011 (Final data collection date for primary outcome measure) |